These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 24515922)

  • 41. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adult mesenchymal stem cells and their potency in the cell-based therapy.
    Das M; Sundell IB; Koka PS
    J Stem Cells; 2013; 8(1):1-16. PubMed ID: 24459809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.
    Ho MS; Mei SH; Stewart DJ
    J Cell Physiol; 2015 Nov; 230(11):2606-17. PubMed ID: 25913273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.
    Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalén M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OP; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson PO; Hägglund H; Mattsson M; Lehtiö J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo KH; Le Blanc K
    Stem Cells Transl Med; 2015 Oct; 4(10):1199-213. PubMed ID: 26285659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bronchopulmonary Dysplasia and Chronic Lung Disease: Stem Cell Therapy.
    Pierro M; Ciarmoli E; Thébaud B
    Clin Perinatol; 2015 Dec; 42(4):889-910. PubMed ID: 26593085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesenchymal stem cell-based therapy for nonhealing wounds: today and tomorrow.
    Li M; Zhao Y; Hao H; Han W; Fu X
    Wound Repair Regen; 2015; 23(4):465-82. PubMed ID: 25877885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MSCs and hyaluronan: sticking together for new therapeutic potential?
    Kota DJ; Prabhakara KS; Cox CS; Olson SD
    Int J Biochem Cell Biol; 2014 Oct; 55():1-10. PubMed ID: 25110036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model.
    Wang W; Jiang Q; Zhang H; Jin P; Yuan X; Wei Y; Hu S
    Regen Med; 2011 Mar; 6(2):179-90. PubMed ID: 21391852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal stem cell based therapy for osteo-diseases.
    Ghasroldasht MM; Irfan-Maqsood M; Matin MM; Bidkhori HR; Naderi-Meshkin H; Moradi A; Bahrami AR
    Cell Biol Int; 2014 Oct; 38(10):1081-5. PubMed ID: 24797260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.
    Toonkel RL; Hare JM; Matthay MA; Glassberg MK
    Am J Respir Crit Care Med; 2013 Jul; 188(2):133-40. PubMed ID: 23306542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease.
    Worthington EN; Hagood JS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice.
    Maron-Gutierrez T; Silva JD; Asensi KD; Bakker-Abreu I; Shan Y; Diaz BL; Goldenberg RC; Mei SH; Stewart DJ; Morales MM; Rocco PR; Dos Santos CC
    Crit Care Med; 2013 Nov; 41(11):e319-33. PubMed ID: 23760104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stem cells: a promising therapy for the acute respiratory distress syndrome.
    Cárdenes N; Cáceres E; Romagnoli M; Rojas M
    Respiration; 2013; 85(4):267-78. PubMed ID: 23428562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats.
    Zhao F; Zhang YF; Liu YG; Zhou JJ; Li ZK; Wu CG; Qi HW
    Transplant Proc; 2008 Jun; 40(5):1700-5. PubMed ID: 18589176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adult stem cells for chronic lung diseases.
    Mora AL; Rojas M
    Respirology; 2013 Oct; 18(7):1041-6. PubMed ID: 23648014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific subsets of mesenchymal stroma cells to treat lung disorders--finding the Holy Grail.
    Rolandsson S; Karlsson JC; Scheding S; Westergren-Thorsson G
    Pulm Pharmacol Ther; 2014 Dec; 29(2):93-5. PubMed ID: 25239767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.
    Walter J; Ware LB; Matthay MA
    Lancet Respir Med; 2014 Dec; 2(12):1016-26. PubMed ID: 25465643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenchymal Stromal Cells to Regenerate Emphysema: On the Horizon?
    Kruk DMLW; Heijink IH; Slebos DJ; Timens W; Ten Hacken NH
    Respiration; 2018; 96(2):148-158. PubMed ID: 29719298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesenchymal stem cells and the treatment of conditions and diseases: the less glittering side of a conspicuous stem cell for basic research.
    Minguell JJ; Allers C; Lasala GP
    Stem Cells Dev; 2013 Jan; 22(2):193-203. PubMed ID: 23025629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.